CAS 170151-24-3|Nepicastat (hydrochloride)
| Common Name | Nepicastat (hydrochloride) | ||
|---|---|---|---|
| CAS Number | 170151-24-3 | Molecular Weight | 331.812 |
| Density | / | Boiling Point | / |
| Molecular Formula | C14H16ClF2N3S | Melting Point | / |
| MSDS | ChineseUSA | Flash Point | / |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | 4-(aminomethyl)-3-[(2S)-5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl]-1H-imidazole-2-thione,hydrochloride |
|---|---|
| Synonym | More Synonyms |
Nepicastat (hydrochloride) BiologicalActivity
| Description | Nepicastat Hcl(SYN117 Hcl; RS-25560-197 Hcl) is a dopamine beta-hydroxylase inhibitor with IC50 of 8.5 ± 0.8 and 9.0 ± 0.8 nM for bovine and human, respectively. IC50 value: 8.5/9.0 nM(bovine/human dopamine beta-hydroxylase)Dopamine beta-hydroxylase is an enzyme that catalyzes the conversion of dopamine to norepinephrine. Nepicastat (SYN117; RS-25560-197) has been studied as a possible treatment for congestive heart failure, and appears to be well tolerated as such. |
|---|---|
| Related Catalog | Signaling Pathways >>Metabolic Enzyme/Protease >>Dopamine β-hydroxylaseResearch Areas >>Cardiovascular Disease |
| References | [1]. Stanley WC, et al. Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase.Br J Pharmacol. 1997 Aug;121(8):1803-9. [2]. Stanley WC, et al. Cardiovascular effects of nepicastat (RS-25560-197), a novel dopamine beta-hydroxylase inhibitor.J Cardiovasc Pharmacol. 1998 Jun;31(6):963-70. [3]. Sabbah HN, et al. Effects of dopamine beta-hydroxylase inhibition with nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.Circulation. 2000 Oct 17;102(16):1990-5. [4]. Beliaev A, et al. Synthesis and biological evaluation of novel, peripherally selective chromanyl imidazolethione-based inhibitors of dopamine beta-hydroxylase.J Med Chem. 2006 Feb 9;49(3):1191-7. |
Chemical & Physical Properties
| Molecular Formula | C14H16ClF2N3S |
|---|---|
| Molecular Weight | 331.812 |
| Exact Mass | 331.072144 |
| PSA | 78.83000 |
| LogP | 4.51490 |
| Appearance of Characters | white to beige |
| InChIKey | DIPDUAJWNBEVOY-PPHPATTJSA-N |
| SMILES | Cl.NCc1c[nH]c(=S)n1C1CCc2c(F)cc(F)cc2C1 |
| Storage condition | ?20°C |
| Water Solubility | DMSO: soluble10mg/mL, clear |
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Phrases | 36/37/38 |
| Safety Phrases | 26 |
| RIDADR | NONH for all modes of transport |
Synonyms
| Nepicastat HCl |
| SYN117 |
| Nepitat HCl |
| Nepicastat hydrochloride |
| UNII-3WK068D17I |
| 5-(Aminomethyl)-1-[(2S)-5,7-difluoro-1,2,3,4-tetrahydro-2-naphthalenyl]-1,3-dihydro-2H-imidazole-2-thione hydrochloride (1:1) |
| 2H-Imidazole-2-thione, 5-(aminomethyl)-1-[(2S)-5,7-difluoro-1,2,3,4-tetrahydro-2-naphthalenyl]-1,3-dihydro-, hydrochloride (1:1) |
| Nepitat hydrochloride |
| Nepicastat (hydrochloride) |
